Evoke Pharma Inc reports results for the quarter ended in March - Earnings Summary

Evoke Pharma

13/05/2021 02:03

* Evoke Pharma Inc  EVOK.OQ  reported a quarterly adjusted loss
of 8 cents​​ per share for the quarter ended in March. The mean
expectation of two analysts for the quarter was for a loss of 6
cents per share.
* Revenue was $90.00 thousand​;  analysts expected $833.00
thousand. 
* Evoke Pharma Inc's reported EPS for the quarter was a loss
of 8 cents​.
* The mean earnings estimate of analysts had fallen by
about 8.3% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Evoke Pharma Inc shares had fallen by 14.8% this quarter and
lost 39.5% so far this year.
* The company reported a quarterly loss of $2.61 million.
* Wall Street's median 12-month price target for Evoke Pharma
Inc is $9.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 13 at 01:03 a.m. GMT.
​All figures in US dollars